Capitolis Liquid Global Markets’s AbbVie ABBV Stock Holding History

Capitolis Liquid Global Markets’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$146M	Buy	673,444 +127	+0%	+$28.2K	0.93%	20
2025 Q4	$154M	Buy	673,317 +82,246	+14%	+$18.7M	0.92%	24
2025 Q3	$137M	Sell	591,071 -51,229	-8%	-$10.4M	1.09%	21
2025 Q2	$119M	Buy	642,300 +30,000	+5%	+$5.58M	0.87%	27
2025 Q1	$128M	Sell	612,300 -37,700	-6%	-$7.33M	1.13%	19
2024 Q4	$116M	Sell	650,000 -160,000	-20%	-$29.4M	1.13%	19
2024 Q3	$160M	Buy	810,000 +770,000	+1,925%	+$144M	1.7%	17
2024 Q2	$6.86M	Hold	40,000	–	–	0.08%	93
2024 Q1	$7.28M	Sell	40,000 -70,000	-64%	-$12.1M	0.12%	93
2023 Q4	$17M	Buy	+110,000	New	+$16M	0.7%	35

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capitolis Liquid Global Markets's ABBV Position: Q1 2026 in Review

Capitolis Liquid Global Markets increased its AbbVie (ABBV) stake by 0.02% in Q1 2026, buying an estimated $28.2K and bringing the position to 673,444 shares worth $146M. The position accounts for 0.93% of the portfolio, ranked #20.

Capitolis Liquid Global Markets first reported a position in ABBV in Q4 2023 and has held it in 10 quarters since. The position peaked at $160M in Q3 2024. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Capitolis Liquid Global Markets held 673,444 shares of AbbVie worth $146M as of Q1 2026.
Capitolis Liquid Global Markets bought 127 AbbVie shares in Q1 2026, an estimated $28.2K.
AbbVie made up 0.93% of Capitolis Liquid Global Markets's portfolio in Q1 2026, its #20 holding.
Capitolis Liquid Global Markets first reported a position in AbbVie in Q4 2023 and has held it in 10 quarters since.
Capitolis Liquid Global Markets's AbbVie position peaked at $160M in Q3 2024.
4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Capitolis Liquid Global Markets's 13F filing for Q1 2026, filed 15 May 2026.